IP Library Granted Patent US 7,365,186
Granted Patent B2
US 7,365,186 · App. 10/703,091 · Granted Apr 29, 2008

Vascular-preferred promoter sequences and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,365,186
App. No.
10/703,091
Granted
Apr 29, 2008
Kind
B2
Abstract

Plant polynucleotide promoter sequences are provided, together with DNA constructs comprising the inventive polynucleotide. Methods for using the inventive constructs for regulating gene expression are provided, along with transgenic plants comprising the inventive constructs.

Claims (10)

1. An isolated polynucleotide selected from the group consisting of SEQ ID NO: 1 to 6.

2. A functional fragment of an isolated polynucleotide of claim 1 , wherein said functional fragment confers vascular-preferred gene expression or xylem-preferred gene expression in a plant cell.

3. The functional fragment of claim 2 , wherein said polynucleotide regulates the expression of an operably-linked gene in a monocotyledenous plant.

4. The functional fragment of claim 2 , wherein said polynucleotide regulates the expression of an operably-linked gene in a dicotyledenous plant.

5. The functional fragment of claim 2 , wherein said polynucleotide is capable of upregulating the expression of an operably-linked gene in a plant.

6. An isolated polynucleotide consisting of a functional fragment of the Eucalyptus grandis caffeic acid 3-O methyl transferase (COMT) promoter, wherein said functional fragment is a functional fragment of SEQ ID NO: 1 that confers vascular-preferred gene expression or xylem-preferred gene expression in a plant cell.

7. The functional fragment of claim 6 , wherein said polynucleotide regulates the expression of an operably-linked gene in a monocotyledenous plant.

8. The functional fragment of claim 6 , wherein said polynucleotide regulates the expression of an operably-linked gene in a dicotyledenous plant.

9. The functional fragment of claim 6 , wherein said polynucleotide is capable of upregulating the expression of an operably-linked gene in a plant.

10. A DNA construct comprising an isolated polynucleotide selected from the group consisting of SEQ ID NO: 1 to 6 operably linked to a nucleic acid sequence, wherein said isolated polynucleotide regulates the expression of the nucleic acid sequence in a plant cell.

Assignments (6)
SECURITY INTEREST Recorded Mar 31, 2015
From: ARBORGEN INC.
To: NBSC, A DIVISION ON SYNOVUS BANK
Reel/Frame 035348/0921 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR'S NAME PREVIOUSLY RECORDED ON REEL 031085 FRAME 0871. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT AND THE ASSIGNOR'S CORRECT NAME SHOULD BE ARBORGEN INC. INSTEAD OF ABORGEN INC. Recorded Aug 28, 2013
From: ARBORGEN INC.
To: NBSC, A DIVISION ON SYNOVUS BANK
Reel/Frame 031098/0188 →
SECURITY AGREEMENT Recorded Aug 26, 2013
From: ABORGEN INC.
To: NBSC, A DIVISION OF SYNOVUS BANK
Reel/Frame 031085/0871 →
CHANGE OF NAME Recorded Aug 15, 2013
From: ARBORGEN, LLC
To: ARBORGEN INC.
Reel/Frame 031029/0795 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 28, 2004
From: AGRIGENESIS BIOSCIENCES LIMITED
To: ARBORGEN, LLC
Reel/Frame 015396/0544 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 28, 2004
From: PHILLIPS, JONATHAN; EAGLETON, CLARE
To: AGRIGENESIS BIOSCIENCES LIMITED
Reel/Frame 015396/0607 →